Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Phathom Pharmaceuticals, Inc. (PHAT)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
24 Jan 2024
TAKEDA PHARMACEUTICAL CO LTD
10% Owner
Phathom Pharmaceuticals, Inc.
(PHAT)
3,755,583
-49%
3,703,703
$8.10
$29,999,996.00
SELL
18 Jan 2024
Henderson Molly
CFO and CBO, Officer
Phathom Pharmaceuticals, Inc.
(PHAT)
98,698
-6%
6,307
$7.75
$48,900.06
BUY
6 Nov 2023
Parikh Asit
Director
Phathom Pharmaceuticals, Inc.
(PHAT)
55,000
+15%
7,500
$7.81
$58,580.00
SELL
1 Nov 2023
Henderson Molly
CFO and CBO, Officer
Phathom Pharmaceuticals, Inc.
(PHAT)
116,869
-9%
12,492
$8.88
$110,870.74
SELL
2 Jun 2023
Henderson Molly
CFO and CBO, Officer
Phathom Pharmaceuticals, Inc.
(PHAT)
68,506
-2%
1,960
$11.41
$22,367.72
SELL
22 May 2023
Henderson Molly
CFO and CBO, Officer
Phathom Pharmaceuticals, Inc.
(PHAT)
70,466
-2%
2,110
$12.87
$27,164.98
BUY
11 Apr 2023
Nabulsi Azmi
Chief Operating Officer, Officer
Phathom Pharmaceuticals, Inc.
(PHAT)
99,567
+11%
10,000
$8.26
$82,600.00
BUY
10 Apr 2023
Parikh Asit
Director
Phathom Pharmaceuticals, Inc.
(PHAT)
23,500
+4%
1,000
$7.55
$7,550.00
SELL
6 Apr 2023
Henderson Molly
CFO and CBO, Officer
Phathom Pharmaceuticals, Inc.
(PHAT)
72,576
-4%
3,439
$7.27
$25,001.53
BUY
6 Apr 2023
Curran Terrie
President and Chief Executive, Director, Officer
Phathom Pharmaceuticals, Inc.
(PHAT)
188,290
+7%
12,919
$7.82
$101,025.29
SELL
1 Mar 2023
Curran Terrie
President and Chief Executive, Director, Officer
Phathom Pharmaceuticals, Inc.
(PHAT)
175,371
-0%
1,436
$8.54
$12,265.02
SELL
1 Mar 2023
Henderson Molly
CFO and CBO, Officer
Phathom Pharmaceuticals, Inc.
(PHAT)
76,015
-2%
2,032
$8.53
$17,334.79
BUY
13 Feb 2023
Parikh Asit
Director
Phathom Pharmaceuticals, Inc.
(PHAT)
22,500
+28%
5,000
$7.73
$38,660.00
SELL
19 Jan 2023
Curran Terrie
President and Chief Executive, Director, Officer
Phathom Pharmaceuticals, Inc.
(PHAT)
176,807
-3%
5,821
$8.20
$47,729.29
BUY
12 Jan 2023
Parikh Asit
Director
Phathom Pharmaceuticals, Inc.
(PHAT)
17,500
+40%
5,000
$7.00
$35,000.00
BUY
16 May 2022
Nabulsi Azmi
Chief Operating Officer, Officer
Phathom Pharmaceuticals, Inc.
(PHAT)
785,700
+2%
20,000
$8.16
$163,288.00
BUY
13 May 2022
Curran Terrie
President and Chief Executive, Director, Officer
Phathom Pharmaceuticals, Inc.
(PHAT)
64,595
+46%
20,500
$7.41
$151,835.30
BUY
12 May 2022
Parikh Asit
Director
Phathom Pharmaceuticals, Inc.
(PHAT)
12,500
+100%
12,500
$8.00
$100,000.00
SELL
14 Mar 2022
TAKEDA PHARMACEUTICAL CO LTD
10% Owner
Phathom Pharmaceuticals, Inc.
(PHAT)
7,459,286
-0%
18
$19.00
$342.00
SELL
4 Nov 2021
TAKEDA PHARMACEUTICAL CO LTD
10% Owner
Phathom Pharmaceuticals, Inc.
(PHAT)
1,100,000
-47%
1,000,001
$20.85
$20,850,020.00
SELL
7 Oct 2021
Socks David A
Director
Phathom Pharmaceuticals, Inc.
(PHAT)
1,211,346
-1%
18,000
$32.58
$586,395.10
SELL
21 Sep 2021
Socks David A
Director
Phathom Pharmaceuticals, Inc.
(PHAT)
1,229,346
-1%
18,000
$32.63
$587,350.70
SELL
16 Aug 2021
Socks David A
Director
Phathom Pharmaceuticals, Inc.
(PHAT)
1,261,137
-1%
18,000
$31.25
$562,538.20
SELL
7 Jul 2021
TAKEDA PHARMACEUTICAL CO LTD
10% Owner
Phathom Pharmaceuticals, Inc.
(PHAT)
871,305
-0%
2,609
$35.05
$91,445.45
SELL
1 Jul 2021
TAKEDA PHARMACEUTICAL CO LTD
10% Owner
Phathom Pharmaceuticals, Inc.
(PHAT)
873,914
-0%
8,326
$35.16
$292,727.16
SELL
28 Jun 2021
Socks David A
Director
Phathom Pharmaceuticals, Inc.
(PHAT)
1,260,945
-3%
40,000
$34.05
$1,361,941.20
SELL
25 Jun 2021
TAKEDA PHARMACEUTICAL CO LTD
10% Owner
Phathom Pharmaceuticals, Inc.
(PHAT)
882,240
-2%
24,501
$35.49
$869,427.40
SELL
23 Jun 2021
TAKEDA PHARMACEUTICAL CO LTD
10% Owner
Phathom Pharmaceuticals, Inc.
(PHAT)
906,741
-1%
11,048
$35.14
$388,198.72
SELL
21 Jun 2021
TAKEDA PHARMACEUTICAL CO LTD
10% Owner
Phathom Pharmaceuticals, Inc.
(PHAT)
917,789
-1%
9,394
$35.31
$331,671.16
SELL
17 Jun 2021
TAKEDA PHARMACEUTICAL CO LTD
10% Owner
Phathom Pharmaceuticals, Inc.
(PHAT)
927,183
-0%
8,703
$35.11
$305,571.16
SELL
14 Jun 2021
TAKEDA PHARMACEUTICAL CO LTD
10% Owner
Phathom Pharmaceuticals, Inc.
(PHAT)
935,886
-0%
2,826
$35.06
$99,079.56
SELL
9 Jun 2021
TAKEDA PHARMACEUTICAL CO LTD
10% Owner
Phathom Pharmaceuticals, Inc.
(PHAT)
938,712
-0%
3,293
$35.19
$115,882.77
SELL
7 Jun 2021
TAKEDA PHARMACEUTICAL CO LTD
10% Owner
Phathom Pharmaceuticals, Inc.
(PHAT)
942,005
-0%
2,364
$35.05
$82,853.20
SELL
2 Jun 2021
TAKEDA PHARMACEUTICAL CO LTD
10% Owner
Phathom Pharmaceuticals, Inc.
(PHAT)
944,369
-0%
4,300
$35.18
$151,274.00
SELL
28 May 2021
TAKEDA PHARMACEUTICAL CO LTD
10% Owner
Phathom Pharmaceuticals, Inc.
(PHAT)
952,636
-2%
20,116
$35.96
$723,434.10
SELL
26 May 2021
TAKEDA PHARMACEUTICAL CO LTD
10% Owner
Phathom Pharmaceuticals, Inc.
(PHAT)
971,064
-2%
20,811
$36.84
$766,699.60
SELL
24 May 2021
TAKEDA PHARMACEUTICAL CO LTD
10% Owner
Phathom Pharmaceuticals, Inc.
(PHAT)
990,144
-2%
21,541
$35.93
$773,888.80
SELL
20 May 2021
TAKEDA PHARMACEUTICAL CO LTD
10% Owner
Phathom Pharmaceuticals, Inc.
(PHAT)
1,011,137
-1%
18,746
$35.50
$665,439.30
SELL
19 May 2021
Socks David A
Director
Phathom Pharmaceuticals, Inc.
(PHAT)
1,303,528
-2%
40,000
$32.64
$1,305,505.60
SELL
14 May 2021
TAKEDA PHARMACEUTICAL CO LTD
10% Owner
Phathom Pharmaceuticals, Inc.
(PHAT)
1,029,883
-0%
100
$35.00
$3,500.00
SELL
12 May 2021
TAKEDA PHARMACEUTICAL CO LTD
10% Owner
Phathom Pharmaceuticals, Inc.
(PHAT)
1,029,983
-1%
11,876
$35.44
$420,892.00
SELL
7 May 2021
TAKEDA PHARMACEUTICAL CO LTD
10% Owner
Phathom Pharmaceuticals, Inc.
(PHAT)
1,041,859
-0%
1,011
$35.03
$35,415.33
SELL
5 May 2021
TAKEDA PHARMACEUTICAL CO LTD
10% Owner
Phathom Pharmaceuticals, Inc.
(PHAT)
1,042,870
-0%
7,138
$35.14
$250,803.05
SELL
3 May 2021
TAKEDA PHARMACEUTICAL CO LTD
10% Owner
Phathom Pharmaceuticals, Inc.
(PHAT)
1,058,298
-3%
33,992
$37.00
$1,257,848.80
SELL
3 May 2021
Nabulsi Azmi
Chief Operating Officer, Officer
Phathom Pharmaceuticals, Inc.
(PHAT)
768,189
-1%
14,500
$37.84
$548,656.10
SELL
5 Apr 2021
Socks David A
Director
Phathom Pharmaceuticals, Inc.
(PHAT)
1,357,427
-2%
40,000
$36.55
$1,462,088.80
SELL
1 Apr 2021
Nabulsi Azmi
Chief Operating Officer, Officer
Phathom Pharmaceuticals, Inc.
(PHAT)
785,301
-1%
14,500
$36.63
$531,101.75
SELL
22 Mar 2021
Curran Terrie
President and Chief Executive, Director, Officer
Phathom Pharmaceuticals, Inc.
(PHAT)
1,140
-90%
11,513
$43.32
$498,750.88
SELL
11 Mar 2021
RA CAPITAL MANAGEMENT, L.P.
10% Owner
Phathom Pharmaceuticals, Inc.
(PHAT)
3,115,008
-18%
710,000
$43.75
$31,062,500.00
SELL
10 Mar 2021
Socks David A
Director
Phathom Pharmaceuticals, Inc.
(PHAT)
1,380,945
-3%
55,000
$47.58
$2,617,090.20
SELL
1 Mar 2021
Nabulsi Azmi
Chief Operating Officer, Officer
Phathom Pharmaceuticals, Inc.
(PHAT)
803,227
-1%
14,500
$45.88
$665,290.10
SELL
19 Feb 2021
Socks David A
Director
Phathom Pharmaceuticals, Inc.
(PHAT)
1,439,910
-4%
70,000
$46.49
$3,254,612.00
SELL
1 Feb 2021
Nabulsi Azmi
Chief Operating Officer, Officer
Phathom Pharmaceuticals, Inc.
(PHAT)
815,584
-1%
14,500
$39.89
$578,440.75
SELL
11 Jan 2021
Socks David A
Director
Phathom Pharmaceuticals, Inc.
(PHAT)
1,553,036
-2%
40,000
$35.70
$1,428,038.00
SELL
4 Jan 2021
Nabulsi Azmi
Chief Operating Officer, Officer
Phathom Pharmaceuticals, Inc.
(PHAT)
823,700
-1%
14,500
$33.61
$487,274.66
SELL
16 Dec 2020
Socks David A
Director
Phathom Pharmaceuticals, Inc.
(PHAT)
1,585,960
-4%
79,658
$43.42
$3,458,895.50
SELL
1 Dec 2020
Nabulsi Azmi
Chief Operating Officer, Officer
Phathom Pharmaceuticals, Inc.
(PHAT)
841,195
-1%
14,500
$44.74
$648,688.06
SELL
9 Nov 2020
Socks David A
Director
Phathom Pharmaceuticals, Inc.
(PHAT)
1,656,860
-1%
30,342
$41.30
$1,253,198.10
SELL
2 Nov 2020
Nabulsi Azmi
Chief Operating Officer, Officer
Phathom Pharmaceuticals, Inc.
(PHAT)
852,700
-1%
14,500
$36.83
$534,026.30
BUY
1 Apr 2020
RA CAPITAL MANAGEMENT, L.P.
10% Owner
Phathom Pharmaceuticals, Inc.
(PHAT)
3,825,008
+3%
117,600
$24.86
$2,923,642.00
BUY
27 Mar 2020
RA CAPITAL MANAGEMENT, L.P.
10% Owner
Phathom Pharmaceuticals, Inc.
(PHAT)
3,707,408
+1%
60,600
$24.58
$1,489,263.60
BUY
29 Oct 2019
Frazier Life Sciences IX, L.P.
10% Owner
Phathom Pharmaceuticals, Inc.
(PHAT)
7,284,269
+16%
1,052,631
$19.00
$19,999,988.00
BUY
29 Oct 2019
Edwards Jonathan S.
Director
Phathom Pharmaceuticals, Inc.
(PHAT)
2,019,877
+108%
1,052,631
$19.00
$19,999,990.00
BUY
29 Oct 2019
COLA MICHAEL F
Director
Phathom Pharmaceuticals, Inc.
(PHAT)
9,798
+100%
9,798
$19.00
$186,162.00
Home